Skip to main content
Signal8

Thompson Jaye

SEC insider (Form 3/4/5 filer). CIK 0001476971. VP Clinical Reg Affairs at Greenwich LifeSciences, Inc. (GLSI). 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 24, 2024. Located in STAFFORD, TX.

Companies Thompson Jaye has filed insider reports for

  • Greenwich LifeSciences, Inc. (GLSI): Officer, VP Clinical Reg Affairs
Thompson Jaye profile photo

Thompson Jaye

CIK: 0001476971

Transaction Breakdown

Open Market Buys (P)2 (66.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Greenwich LifeSciences, Inc. logo
GLSI

Greenwich LifeSciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Greenwich LifeSciences, Inc. logo
    GLSI

    Greenwich LifeSciences, Inc.

    Dec 24, 2024
    Award

    Stock Options

    Direct
    149.8K shares-
  • Greenwich LifeSciences, Inc. logo
    GLSI

    Greenwich LifeSciences, Inc.

    Nov 21, 2024
    Purchase
    Direct
    1K shares at avg. $12.91$13K
  • Greenwich LifeSciences, Inc. logo
    GLSI

    Greenwich LifeSciences, Inc.

    Aug 12, 2024
    Purchase
    Direct
    800 shares at avg. $13.85$11K

1-3 of 3